Editorial モデルの実力を評価 2015年7月1日 Nature Biotechnology 33, 7 doi: 10.1038/nbt.3279 The time has come to systematically assess the pros and cons of different mouse models as predictors of patient responses to cancer therapies. Full text PDF 目次へ戻る
